Impact BioMedical, Inc. (IBO)
4.68
-0.16
(-3.31%)
USD |
NYAM |
Oct 06, 16:00
4.62
-0.06
(-1.28%)
After-Hours: 20:00
Impact BioMedical Shareholders Equity (Quarterly) : 10.77M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.77M |
| March 31, 2026 | 11.46M |
| December 31, 2025 | 12.61M |
| September 30, 2025 | -11.81M |
| June 30, 2025 | -10.34M |
| March 31, 2025 | 3.843M |
| December 31, 2024 | 4.259M |
| September 30, 2024 | 31.35M |
| June 30, 2024 | 23.37M |
| March 31, 2024 | 24.26M |
| December 31, 2023 | 25.22M |
| September 30, 2023 | 26.52M |
| Date | Value |
|---|---|
| June 30, 2023 | 27.62M |
| March 31, 2023 | 28.90M |
| December 31, 2022 | 29.56M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 36.61M |
| September 30, 2021 | |
| June 30, 2021 | 37.10M |
| March 31, 2021 | |
| December 31, 2020 | 37.91M |
| September 30, 2020 | 0.039M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 219.26M |
| Enveric Biosciences, Inc. | 8.082M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.74M |
| Total Liabilities (Quarterly) | 2.733M |
| Current Ratio | 0.1565 |
| Net Debt Paydown Yield | 3.69% |